Carcinoma: all 6,719 studies

Page 8 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.

• The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPRRecruitingNCT05854823Not applicable
• Buccal Cancer Resection Ultrasound GuidedNot yet recruitingNCT05852665Not applicable
• Application of Chromosomal Instability in Early Diagnosis of Biliary Tract CarcinomaRecruitingNCT05845554
• Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) PatientsRecruitingNCT05844046Phase 2
• 3D Ultrasound, Specimen Examination by Surgeon, and MRI in Surgical Margin AssessmentNot yet recruitingNCT05843032Not applicable
• Lenvatinib Plus Tislelizumab With or Without TACE in First-line Treatment of Unresectable HCCRecruitingNCT05842317Phase 1/2
• The Adverse Event of Mitotane Therapy in Patients With Adrenocortical CarcinomaNot yet recruitingNCT05839886
• A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable MTM HCCRecruitingNCT05839197Phase 2
• Cadonilimab in Combination With Chemotherapy for Locally Advaced Esophageal Squamous Cell CarcinomaNot yet recruitingNCT05833971Phase 2
• Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell CarcinomaRecruitingNCT05833594
• First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)RecruitingNCT05832827Phase 2
• Improving Hepatocellular Carcinoma ScreeningRecruitingNCT05828446Not applicable
• A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)RecruitingNCT05824975Phase 1/2
• Gemcitabine Plus S1 and Tislelizumab in the First Line Therapy of Advanced Biliary Tract CarcinomaNot yet recruitingNCT05822453Phase 2
• The Effect of Prebiotic Inulin on Patients Affected by R/M HNSCC Treated With Immune Checkpoint InhibitorsRecruitingNCT05821751Not applicable
• Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal CarcinomaNot yet recruitingNCT05821452Phase 2
• HAIC Combined With Cadonilimab and Bevacizumab as First-line Therapy in Unresectable Hepatocellular CarcinomaNot yet recruitingNCT05821361Phase 2
• AI-aided Optical Coherence Tomography for the Detection of Basal Cell CarcinomaRecruitingNCT05817279
• Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted TherapyRecruitingNCT05811481
• Single-Dose Intravesical Chemotherapy After Diagnostic URSNot yet recruitingNCT05810623Phase 3
• Immunotherapy and Radioembolisation for Metastatic Hepatocellular CarcinomaRecruitingNCT05809869Phase 2
• Elective vs Therapeutic Neck Dissection in Treatment of Patients With Clinical T1/2N1M0 Oral Squamous Cell CarcinomaNot yet recruitingNCT05806073Not applicable
• Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical TherapyNot yet recruitingNCT05803915Phase 2
• A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian CancerRecruitingNCT05801783Early Phase 1
• Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell CarcinomaNot yet recruitingNCT05798455Phase 1/2
• Immunotherapy After Radiotherapy in Elderly ESCCNot yet recruitingNCT05791136Phase 2
• Cadonilimab (AK104) in the Treatment of Nasopharyngeal CarcinomaRecruitingNCT05790200Phase 2
• Safety and Efficacy of Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1 Stage Renal CarcinomaRecruitingNCT05790122
• HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid TumorRecruitingNCT05787535Phase 1
• A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell CarcinomaRecruitingNCT05783921Phase 1/2
• To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307RecruitingNCT05783570Phase 1
• A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPCNot yet recruitingNCT05780294Phase 3
• The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCCRecruitingNCT05778253
• A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUCRecruitingNCT05775874Phase 2
• Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCCRecruitingNCT05775419Not applicable
• Toripalimab Maintenance for Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT05773079Phase 2
• Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant ChemotherapyRecruitingNCT05772208Phase 3
• Effect of Hepatectomy on the Prognosis of Patients With Nasopharyngeal Carcinoma Liver MetastasesRecruitingNCT05771025Not applicable
• BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid LeukemiaRecruitingNCT05768932Phase 1
• Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence FactorsRecruitingNCT05768464Phase 2
• The Application of Serum DNA Methylation for Patients With HCCRecruitingNCT05764551Not applicable
• Ate-Bev Early Response Prediction Model in Advanced HCCRecruitingNCT05763277
• A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.RecruitingNCT05760391Not applicable
• Toripalimab Plus Etoposide and Platinum-based Chemotherapy for Genitourinary Small Cell CarcinomaRecruitingNCT05760053Phase 2
• Identification and Prognostic Value of Key Genes in Hepatocellular CarcinomaRecruitingNCT05759858
• An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell CarcinomaNot yet recruitingNCT05759325
• The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN TrialRecruitingNCT05753839Not applicable
• A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular CarcinomaNot yet recruitingNCT05752890
• Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC PatientsRecruitingNCT05743504Phase 1/2
• Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSCRecruitingNCT05741073
• Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell CarcinomaRecruitingNCT05740995
• The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological TelesurgeryRecruitingNCT05739812Not applicable
• Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3RecruitingNCT05738980Not applicable
• Lenvatinib Combined With TACE and Camrelizumab in Conversion Resection for Advanced Hepatocellular Carcinoma (LEN-TAC Study)RecruitingNCT05738616Phase 3
• PD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCCRecruitingNCT05737563Phase 3
• Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian CancerRecruitingNCT05737303Phase 3
• Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic CarcinomaRecruitingNCT05733910Not applicable
• CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid TumorsRecruitingNCT05733000Phase 2
• SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCCNot yet recruitingNCT05732662Phase 2
• Effect of a SI-MMC on the IVR Rate After Ureteroscopy for UTUCRecruitingNCT05731622
• Efficacy and Safety of a Fully Covered Self-Expandable Metal Stent for Unresectable HCCRecruitingNCT05729867Not applicable
• Neoadjuvant Nivolumab, Docetaxel, Cisplatin Therapy Followed by Surgery and Radiation Therapy for Resectable High Grade Salivary Gland CarcinomaRecruitingNCT05727410Phase 2
• Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial CarcinomaRecruitingNCT05723991Phase 4
• A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic AgentsRecruitingNCT05718492Not applicable
• SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH)Not yet recruitingNCT05718232Phase 3
• Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal CarcinomaRecruitingNCT05717790Not applicable
• Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing TreatmentNot yet recruitingNCT05717764Phase 3
• Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular CarcinomaRecruitingNCT05717738
• Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular CarcinomaRecruitingNCT05713994
• Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCCNot yet recruitingNCT05711823Phase 3
• Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine NeoplasmsEnrolling by invitationNCT05709171Phase 2
• Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal CarcinomaRecruitingNCT05707819
• A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell CarcinomaRecruitingNCT05705583
• CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)RecruitingNCT05704192
• Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)RecruitingNCT05703750
• Anti-PD-1/PD-L1 Antibodies Plus S-adenosyl-methionine Treatment in Patients With Advanced-Stage Hepatocellular CarcinomaRecruitingNCT05701553
• High Intensity Focused Ultrasound (HIFU) Treatment of Basal Cell CarcinomaRecruitingNCT05698706Not applicable
• Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid TumoursNot yet recruitingNCT05698238Phase 1
• Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal VestibuleRecruitingNCT05693116
• Single Centre Prospective Evaluation of 68Gallium-FAPI PET/MRI in Hepatocellular CarcinomaRecruitingNCT05687747Phase 1
• Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor BoardsNot yet recruitingNCT05681949Not applicable
• Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial HyperplasiaRecruitingNCT05675787Phase 2
• Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular CarcinomaRecruitingNCT05675462Phase 1
• Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant ChemotherpyRecruitingNCT05674305Phase 3
• A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor MalignanciesRecruitingNCT05669430Phase 1/2
• Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TCRecruitingNCT05668962Phase 2
• A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver CancerNot yet recruitingNCT05660213
• PErsonalized TReatment for Endometrial CarcinomaRecruitingNCT05655260Not applicable
• EBV CAR-T Cells for Nasopharyngeal CarcinomaRecruitingNCT05654077Early Phase 1
• Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCCRecruitingNCT05652920Phase 1/2
• SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPCRecruitingNCT05652192Phase 2
• Monitoring and Early Response Evaluation Using HPV DNA - A Study on Patients With HPV-positive Throat Cancer (MER-HPV)RecruitingNCT05649865
• Liquid Biopsy for Early DiagNosis of Squamous Cell Carcinoma of the HeAd and NeCk rEgionRecruitingNCT05645783
• Applying Artificial Intelligence to Optimize Early-stage Hepatocellular Carcinoma Treatment Based on Multi-modal ImageRecruitingNCT05627297
• Refinement and Validation of a Diagnostic Model (GAMAD) for Early Detection of Hepatocellular CarcinomaRecruitingNCT05626985
• Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal CarcinomaRecruitingNCT05626829Phase 2
• Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCCRecruitingNCT05626569Phase 2
• A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and ChemotherapyNot yet recruitingNCT05622474Not applicable
• Quantifying Systemic Immunosuppression to Personalize Cancer TherapyRecruitingNCT05621837
• Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-TRecruitingNCT05620732Not applicable

← Carcinoma overview